Kevin N. Heller
CIK 1775716 · View on SEC EDGAR ↗
First SEC filing: Oct. 1, 2021 · Latest: Oct. 1, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 21, 2022 | JSPRW | A | 7,500 | — | — | 7,500 Direct | — | Acquired | (price as of 2026-08-20) |
| July 14, 2020 | NXTC | M | 27,229 | — | — | 38,119 Direct | -41.67% | Disposed | (price as of 2026-08-20) |
| July 14, 2020 | NXTC | M | 27,229 | $1.77 | $48,195 | 49,011 Direct | +125.01% | Acquired | -69.4% (price as of 2026-08-20) |
| Feb. 28, 2020 | NXTC | A | 100,050 | — | — | 100,050 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 21, 2022 | JSPRW | Stock Option (right to buy) | Voting Common Stock (7,500) | $3.54 | March 21, 2032 | 7,500 | Acquired |
| July 14, 2020 | NXTC | Employee Stock Option (Right to Buy) | Common Stock (27,229) | $1.77 | Aug. 27, 2028 | 27,229 | Disposed |
| Feb. 28, 2020 | NXTC | Employee Stock Option (Right to Buy) | Common Stock (100,050) | $41.76 | Feb. 27, 2030 | 100,050 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 1, 2021 | JSPRW | Stock Option (right to buy)→ Common Stock (657,769) | 657,769 | Direct |
| May 8, 2019 | NXTC | Common Stock | 21,782 | Direct |
| May 8, 2019 | NXTC | Employee Stock Option (Right to Buy)→ Common Stock (65,348) | 65,348 | Direct |
| May 8, 2019 | NXTC | Employee Stock Option (Right to Buy)→ Common Stock (62,237) | 62,237 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
NXTC
M.D. Former Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $369,000 | — | — | — | $133,488 | — | $2,806 | $505,294 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $454,395 | — | — | — | $163,592 | — | — | $617,987 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.